Hypertrophic cardiomyopathy: Mutations to mechanisms to therapies

Hypertrophic cardiomyopathy (HCM) affects more than 1 in 500 people in the general population with an extensive burden of morbidity in the form of arrhythmia, heart failure, and sudden death. More than 25 years since the discovery of the genetic underpinnings of HCM, the field has unveiled significa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawana, Masataka, Spudich, James A., Ruppel, Kathleen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Physiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548533/
https://www.ncbi.nlm.nih.gov/pubmed/36225299
http://dx.doi.org/10.3389/fphys.2022.975076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548533/
https://www.ncbi.nlm.nih.gov/pubmed/36225299
http://dx.doi.org/10.3389/fphys.2022.975076

Ejemplares similares